This company has been marked as potentially delisted and may not be actively trading. ETAO International (ETAO) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock ETAO vs. CMRA, GNCA, GNCAQ, NVOS, ARDS, BTTX, CALA, STAB, NMRD, and UPHLShould you be buying ETAO International stock or one of its competitors? The main competitors of ETAO International include Comera Life Sciences (CMRA), Genocea Biosciences (GNCA), Genocea Biosciences (GNCAQ), Novo Integrated Sciences (NVOS), Aridis Pharmaceuticals (ARDS), Better Therapeutics (BTTX), Calithera Biosciences (CALA), Statera Biopharma (STAB), Nemaura Medical (NMRD), and UpHealth (UPHL). These companies are all part of the "medical" sector. ETAO International vs. Its Competitors Comera Life Sciences Genocea Biosciences Genocea Biosciences Novo Integrated Sciences Aridis Pharmaceuticals Better Therapeutics Calithera Biosciences Statera Biopharma Nemaura Medical UpHealth Comera Life Sciences (NASDAQ:CMRA) and ETAO International (NASDAQ:ETAO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations. Do institutionals and insiders hold more shares of CMRA or ETAO? 0.2% of ETAO International shares are owned by institutional investors. 8.9% of Comera Life Sciences shares are owned by insiders. Comparatively, 20.8% of ETAO International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media refer more to CMRA or ETAO? In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled ETAO International'saverage media sentiment score. Company Overall Sentiment Comera Life Sciences Neutral ETAO International Neutral Which has stronger valuation and earnings, CMRA or ETAO? Comera Life Sciences has higher earnings, but lower revenue than ETAO International. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioComera Life Sciences$1.00M0.01-$18MN/AN/AETAO International$58.89M0.00-$896.68MN/AN/A Is CMRA or ETAO more profitable? Company Net Margins Return on Equity Return on Assets Comera Life SciencesN/A N/A N/A ETAO International N/A N/A N/A Which has more volatility and risk, CMRA or ETAO? Comera Life Sciences has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Comparatively, ETAO International has a beta of 1.92, suggesting that its stock price is 92% more volatile than the S&P 500. SummaryETAO International beats Comera Life Sciences on 4 of the 5 factors compared between the two stocks. Get ETAO International News Delivered to You Automatically Sign up to receive the latest news and ratings for ETAO and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ETAO vs. The Competition Export to ExcelMetricETAO InternationalOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$2K$33.61M$5.75B$9.60BDividend YieldN/AN/A4.54%4.09%P/E RatioN/AN/A30.4025.01Price / SalesN/A0.60415.24176.62Price / CashN/A54.0337.3459.16Price / BookN/A0.398.956.28Net Income-$896.68M-$7.06M$3.26B$265.47M ETAO International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ETAOETAO InternationalN/AN/AN/AN/A$2K$58.89M0.003,600CMRAComera Life SciencesN/A$0.00flatN/AN/A$6K$1.00M0.002GNCAGenocea BiosciencesN/AN/AN/AN/A$6K$1.91M0.0070GNCAQGenocea BiosciencesN/AN/AN/AN/A$6KN/A0.0070NVOSNovo Integrated SciencesN/A$0.00-66.7%N/A-99.9%$6K$13.52M0.00170Gap DownARDSAridis PharmaceuticalsN/AN/AN/AN/A$5KN/A0.0030BTTXBetter TherapeuticsN/AN/AN/AN/A$5KN/A0.0040CALACalithera Biosciences0.6362 of 5 stars$0.00flatN/A-98.4%$5KN/A0.0060STABStatera BiopharmaN/A$0.00flatN/AN/A$5KN/A0.0020NMRDNemaura Medical1.2204 of 5 stars$0.00flatN/AN/A$4K$3.02K0.0040UPHLUpHealth0.3647 of 5 stars$0.00flatN/A-99.9%$4K$130M0.001,750 Related Companies and Tools Related Companies CMRA Alternatives GNCA Alternatives GNCAQ Alternatives NVOS Alternatives ARDS Alternatives BTTX Alternatives CALA Alternatives STAB Alternatives NMRD Alternatives UPHL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ETAO) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ETAO International Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ETAO International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access